It’s easy to become a member. Start here so we can help your business thrive. View membership benefits.
A clinical trial conducted at the Edwards Comprehensive Cancer Center and the Marshall University Joan C. Edwards School of Medicine has returned positive results in reducing the side effects of aromatase inhibitors in patients with breast cancer.
Aromatase inhibitors are a standard treatment for hormone receptor-positive breast cancer in postmenopausal women. These treatments can help prevent a return of the disease by blocking the effects of estrogen. A common side effect of the treatment is joint and muscle pain which at times can be debilitating and cause patients not to complete their treatments.